Tumor human papillomavirus: a potential test for cervical cancer prognosis.
作者信息
Le Tan Minh, Chong Gun Oh, Han Hyung Soo
机构信息
Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Korea.
BK21 Four Program, School of Medicine, Kyungpook National University, Daegu, Korea.
出版信息
Transl Cancer Res. 2023 Mar 31;12(3):684-687. doi: 10.21037/tcr-22-2790. Epub 2023 Feb 20.
Abstract
摘要
相似文献
1
Tumor human papillomavirus: a potential test for cervical cancer prognosis.肿瘤人乳头瘤病毒：一种用于宫颈癌预后的潜在检测方法。
Transl Cancer Res. 2023 Mar 31;12(3):684-687. doi: 10.21037/tcr-22-2790. Epub 2023 Feb 20.
2
The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.高危型人乳头瘤病毒相关长非编码 RNA 在宫颈鳞癌预后中的作用。
DNA Cell Biol. 2020 Apr;39(4):645-653. doi: 10.1089/dna.2019.5167. Epub 2020 Feb 11.
3
Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths.估计人乳头瘤病毒疫苗接种对宫颈癌病例和死亡人数的潜在总体影响。
Vaccine. 2014 Feb 3;32(6):733-9. doi: 10.1016/j.vaccine.2013.11.049. Epub 2013 Nov 26.
4
Survival‑related DLEU1 is associated with HPV infection status and serves as a biomarker in HPV‑infected cervical cancer.生存相关的 DLEU1 与 HPV 感染状态相关，并可作为 HPV 感染的宫颈癌的生物标志物。
Mol Med Rep. 2022 Mar;25(3). doi: 10.3892/mmr.2022.12593. Epub 2022 Jan 11.
5
Relationship between vaginal microecological changes and oncogene E6/E7 and high-risk human papillomavirus infection.阴道微生态变化与癌基因E6/E7及高危型人乳头瘤病毒感染之间的关系
J Obstet Gynaecol. 2023 Dec;43(1):2161349. doi: 10.1080/01443615.2022.2161349.
6
Distribution of human papillomavirus genotypes in archival cervical lesions in eastern inner Mongolian autonomous region, China.中国内蒙古自治区东部地区存档宫颈病变中人类乳头瘤病毒基因型的分布情况
Int J Gynecol Cancer. 2009 Jul;19(5):919-23. doi: 10.1111/IGC.0b013e3181a58fef.
7
Detection of Alpha, Beta, Gamma, and Unclassified Human Papillomaviruses in Cervical Cancer Samples From Mexican Women.在墨西哥女性宫颈癌样本中检测α、β、γ和未分类的人乳头瘤病毒
Front Cell Infect Microbiol. 2020 Jun 9;10:234. doi: 10.3389/fcimb.2020.00234. eCollection 2020.
8
HPV and radiosensitivity of cervical cancer: a narrative review.人乳头瘤病毒与宫颈癌的放射敏感性：一项叙述性综述
Ann Transl Med. 2022 Dec;10(24):1405. doi: 10.21037/atm-22-5930.
9
A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.一种基于人乳头瘤病毒 DNA 和肿瘤大小的风险分层新标志物，用于预测局部晚期宫颈癌的生存。
Int J Gynecol Cancer. 2019 Mar;29(3):459-465. doi: 10.1136/ijgc-2018-000095. Epub 2019 Feb 7.
10
HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize mA-MYC expression.HPV E6/E7 通过调节 IGF2BP2 稳定 mA-MYC 表达促进宫颈癌的有氧糖酵解。
Int J Biol Sci. 2022 Jan 1;18(2):507-521. doi: 10.7150/ijbs.67770. eCollection 2022.
引用本文的文献
1
Cuproptosis-related genes signature could predict prognosis and the response of immunotherapy in cervical cancer.铜死亡相关基因特征可预测宫颈癌的预后及免疫治疗反应。
Transl Cancer Res. 2025 Jan 31;14(1):129-140. doi: 10.21037/tcr-24-641. Epub 2025 Jan 21.
本文引用的文献
1
Performance of the Human Papillomavirus E6/E7 mRNA Assay in the Primary Screening of Cervical Cancer: Opportunistic Screening in Fujian, China.人乳头瘤病毒E6/E7 mRNA检测在宫颈癌初筛中的性能：中国福建的机会性筛查
Int J Womens Health. 2022 Oct 25;14:1519-1530. doi: 10.2147/IJWH.S383431. eCollection 2022.
2
Human Papillomavirus Infection Determines Prognosis in Cervical Cancer.人乳头瘤病毒感染决定宫颈癌的预后。
J Clin Oncol. 2022 May 10;40(14):1522-1528. doi: 10.1200/JCO.21.01930. Epub 2022 Jan 25.
3
Human Papillomavirus Vaccination and Trends in Cervical Cancer Incidence and Mortality in the US.人乳头瘤病毒疫苗接种与美国宫颈癌发病率和死亡率的趋势
JAMA Pediatr. 2022 Mar 1;176(3):313-316. doi: 10.1001/jamapediatrics.2021.4807.
4
HPV transcript expression affects cervical cancer response to chemoradiation.HPV 转录表达影响宫颈癌对放化疗的反应。
JCI Insight. 2021 Aug 23;6(16):e138734. doi: 10.1172/jci.insight.138734.
5
Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial.中国宫颈癌筛查中高危型人乳头瘤病毒检测的效果：一项多中心、开放标签、随机临床试验。
JAMA Oncol. 2021 Feb 1;7(2):263-270. doi: 10.1001/jamaoncol.2020.6575.
6
HPV negative cervical cancers and primary HPV screening.人乳头瘤病毒阴性宫颈癌与初次人乳头瘤病毒筛查
Facts Views Vis Obgyn. 2018 Jun;10(2):107-113.
7
Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.治疗前人乳头瘤病毒 DNA 状态对宫颈癌的预后价值。
Gynecol Oncol. 2018 Jan;148(1):97-102. doi: 10.1016/j.ygyno.2017.11.003. Epub 2017 Nov 15.
8
Prognostic value of HPV DNA status in cervical cancer before treatment: a systematic review and meta-analysis.治疗前宫颈癌中HPV DNA状态的预后价值：一项系统评价和荟萃分析。
Oncotarget. 2017 Jun 16;8(39):66352-66359. doi: 10.18632/oncotarget.18558. eCollection 2017 Sep 12.
9
Independent prognostic role of human papillomavirus genotype in cervical cancer.人乳头瘤病毒基因型在宫颈癌中的独立预后作用。
BMC Infect Dis. 2017 Jun 5;17(1):391. doi: 10.1186/s12879-017-2465-y.
10
Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer.人乳头瘤病毒感染对免疫系统的影响及其在宫颈癌病程中的作用。
Oncol Lett. 2015 Aug;10(2):600-606. doi: 10.3892/ol.2015.3295. Epub 2015 May 29.
Zotero 插件